The U.S. Federal Trade Commission is cracking down on the pharmaceutical industry to address concerns about high prescription drug costs. The Biden administration is using the FTC to send a message to drug companies that monopolistic practices that harm consumers will not be tolerated. The FTC is targeting rebates, mergers, and patents that keep generic rivals at bay. The agency has been successful in its efforts, and this update provides information on their progress in addressing these issues. The overall goal is to lower drug prices for consumers.
Source link
FTC says it’s on ‘an incredible winning streak’ against pharma
